- Can We Trust Safety of Tenofovir Disoproxil in Patients with Decompensated Cirrhosis?
-
Oh H, Jun DW
- KMID: 2395377
- Gut Liver.
- 2017 Nov;11(6):743-744.
- doi: 10.5009/gnl17401
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Bone Scintigraphy and Tenofovir-Induced Osteomalacia in Chronic Hepatitis B
-
Hoe AK, Fong LY
- KMID: 2446904
- Nucl Med Mol Imaging.
- 2017 Jun;51(2):195-196.
- doi: 10.1007/s13139-016-0395-z
Tenofovir, used in the treatment of chronic hepatitis B and HIV, is known for its side effects on the kidneys and bones. We share interesting images of a patient with... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Tenofovir on the Prevention of Hepatitis B Transmission in Mothers with High Viral Load
-
Kwon JH
- KMID: 2383416
- Korean J Gastroenterol.
- 2017 Mar;69(3):199-201.
- doi: 10.4166/kjg.2017.69.3.199
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
-
Lee YB, Lee JH
- KMID: 2400667
- Clin Mol Hepatol.
- 2017 Sep;23(3):219-221.
- doi: 10.3350/cmh.2017.0045
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Tenofovir-associated Fanconi Syndrome in Patient with Chronic Hepatitis B
-
Kim D, Lee J, Kim DH, Kang K, Suh SJ, Jung YK, Yim HJ
- KMID: 2383462
- Korean J Gastroenterol.
- 2016 Dec;68(6):317-320.
- doi: 10.4166/kjg.2016.68.6.317
Tenofovir disoproxil fumarate (TDF) is one of the most widely used treatment options for human immunodeficiency virus (HIV) and HBV infections. Despite its efficacy and safety, some cases of nephrotoxicity... -
- CITED
-
- Close
- SHARE
-
- Close
- Lamivudine: fading into the mists of time
-
Choi J, Lim YS
- KMID: 2406039
- Clin Mol Hepatol.
- 2017 Dec;23(4):314-315.
- doi: 10.3350/cmh.2017.0110
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Drug Utilization in Patients with Chronic Hepatitis B
-
Lee YJ, Bae SJ, Je NK
- KMID: 2358238
- Korean J Clin Pharm.
- 2016 Sep;26(3):220-229.
- doi: 10.0000/kjcp.2016.26.3.220
BACKGROUND: The treatment goal for patients with chronic hepatitis B infection is to prevent progression of the disease to cirrhosis and hepatocellular carcinoma. Current therapies include standard and pegylated interferon-alfa... -
- CITED
-
- Close
- SHARE
-
- Close
- Entecavir Resistance at rtS202, rtM250 May Cause Poor Viral Response to Tenofovir-based Rescue Therapy in Chronic Hepatitis B
-
Kim SE, Park JW, Kim HS, Suk KT, Jang MK, Park SH, Lee MS, Kim DJ, Park CK
- KMID: 2268953
- Korean J Med.
- 2015 Nov;89(5):527-536.
- doi: 10.3904/kjm.2015.89.5.527
BACKGROUND/AIMS: Long-term use of nucleos(t)ide analogues (NA) may lead to genotypic and/or phenotypic resistance of the hepatitis B virus (HBV). We investigated the efficacy of tenofovir-based rescue therapy in chronic... -
- CITED
-
- Close
- SHARE
-
- Close
- Long Term Efficacy of Antiviral Therapy: Mortality and Incidence of Hepatocellular Carcinoma
-
Lee HW
- KMID: 2464183
- Korean J Gastroenterol.
- 2019 Nov;74(5):251-257.
- doi: 10.4166/kjg.2019.74.5.251
Multiple studies have shown that oral antiviral therapies reduced the incidence of hepatocellular carcinoma (HCC) and improved the survival of patients with chronic hepatitis B when compared with that of... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
-
Park CH, Jung SW, Shin JW, Bae MA, Lee YI, Park YT, Chung HS, Park NH
- KMID: 2363033
- Clin Mol Hepatol.
- 2016 Mar;22(1):152-159.
- doi: 10.3350/cmh.2016.22.1.152
BACKGROUND/AIMS: Tenofovir disoproxil fumarate (TDF) exhibits similar antiviral efficacy against treatment-naïve and lamivudine (LAM)-resistant chronic hepatitis B (CHB). However, there are few clinical reports on the antiviral effects of TDF-LAM... -
- CITED
-
- Close
- SHARE
-
- Close
- Unmet need in chronic hepatitis B management
-
Liang LY, Wong GL
- KMID: 2451920
- Clin Mol Hepatol.
- 2019 Jun;25(2):172-180.
- doi: 10.3350/cmh.2018.0106
Despite all these exciting developments, there remain some unmet needs in the management for patients with chronic hepatitis B (CHB). As majority of CHB patients are going to use oral... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Antiviral Resistance in Chronic Hepatitis B
-
Lim YS
- KMID: 2412184
- Gut Liver.
- 2017 Mar;11(2):189-195.
- doi: 10.5009/gnl15562
The primary goal of therapy for chronic hepatitis B (CHB) is to prevent liver disease progression. Hepatitis B surface antigen (HBsAg) seroclearance or seroconversion is regarded as an optimal endpoint... -
- CITED
-
- Close
- SHARE
-
- Close
- Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
-
Cho H, Cho Y, Cho EJ, Lee JH, Yu SJ, Oh KH, Lee K, Mustika S, Yoon JH, Kim YJ
- KMID: 2373127
- Clin Mol Hepatol.
- 2016 Jun;22(2):286-291.
- doi: 10.3350/cmh.2015.0066
Tenofovir disoproxil fumarate (TDF) is effective against chronic hepatitis B (CHB) infection and its use is increasing rapidly worldwide. However, it has been established that TDF is associated with renal... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of long-term tenofovir disoproxil fumarate therapy in chronic hepatitis B patients with partial virologic response in real practice
-
Song JE, Lee CH, Kim BS
- KMID: 2457310
- Korean J Intern Med.
- 2019 Jul;34(4):802-810.
- doi: 10.3904/kjim.2019.037
BACKGROUND/AIMS: The optimal management of chronic hepatitis B (CHB) patients with partial virologic response (PVR) to tenofovir disoproxil fumarate (TDF) remains unclear. We aimed to evaluate the long-term efficacy of... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
-
Kim DS, Jeon MY, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SU
- KMID: 2459790
- Clin Mol Hepatol.
- 2019 Sep;25(3):283-293.
- doi: 10.3350/cmh.2018.0054
BACKGROUND/AIMS: The influence of hepatic steatosis (HS) on chronic hepatitis B (CHB) is unclear. We evaluated the influence of the degree of HS, assessed using the controlled attenuation parameter (CAP)... -
- CITED
-
- Close
- SHARE
-
- Close
- Real World Experience of Telbivudine Versus Entecavir in Patients with Chronic Hepatitis B, Including Long-Term Outcomes after Treatment Modification
-
Choi JW, Kim SH, Seo JH, Cho YS, Won SY, Park BK, Jeon HH, Lee YK, Lee CK
- KMID: 2407861
- Yonsei Med J.
- 2018 May;59(3):383-388.
- doi: 10.3349/ymj.2018.59.3.383
PURPOSE: To estimate long-term outcomes after treatment modification in patients with chronic hepatitis B (CHB) treated with entecavir (ETV) and telbivudine (LdT). MATERIALS AND METHODS: The study enrolled 131 nucleos(t)ide analogue... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatic Infarction Caused by Portal Vein Thrombophlebitis Misdiagnosed as Infiltrative Hepatic Malignancy with Neoplastic Thrombus
-
Shim M, Yang TY, Cho NG, Woo A, Kim E, Park K, Lee JH, Lee YB, Hwang SG, Rim KS, Park H
- KMID: 2358719
- Korean J Gastroenterol.
- 2016 Sep;68(3):156-160.
- doi: 10.4166/kjg.2016.68.3.156
Portal vein thrombosis (PVT) is a form of venous thrombosis that usually presents in chronic form without any sequalae in patients with hepatocellular carcinoma (HCC) or liver cirrhosis. Accurate differential... -
- CITED
-
- Close
- SHARE
-
- Close
- The efficacy of tenofovir-based therapy in patients showing suboptimal response to entecavir-adefovir combination therapy
-
Kim JH, Ahn SH, Ko SY, Choe WH, Kim KH, Kwon SY
- KMID: 2373120
- Clin Mol Hepatol.
- 2016 Jun;22(2):241-249.
- doi: 10.3350/cmh.2015.0053
BACKGROUND/AIMS: Before tenofovir (TDF) become available in South Korea, combination therapy with entecavir (ETV) and adefovir (ADV) was the most potent regimen for chronic hepatitis B (CHB) patients who fail... -
- CITED
-
- Close
- SHARE
-
- Close
- Antiviral Efficacy of Tenofovir Monotherapy in Children with Nucleos(t)ide-naive Chronic Hepatitis B
-
Choe JY, Ko JS, Choe BH, Kim JE, Kang B, Lee KJ, Yang HR
- KMID: 2399406
- J Korean Med Sci.
- 2018 Jan;33(2):e11.
- doi: 10.3346/jkms.2018.33.e11
BACKGROUND: The purpose was to compare the efficacy between tenofovir disoproxil fumarate (TDF) and lamivudine (LMV) in children with nucleos(t)ide-naive chronic hepatitis B (CHB) infection. Patients with CHB were treated... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis
-
Park J, Jung KS, Lee HW, Kim BK, Kim SU, Kim DY, Ahn SH, Han KH, Park JY
- KMID: 2395388
- Gut Liver.
- 2017 Nov;11(6):828-834.
- doi: 10.5009/gnl16484
BACKGROUND/AIMS: The renal effects of nucleos(t)ide analogs in patients with chronic hepatitis B are controversial. We aimed to compare the impact of entecavir (ETV) and tenofovir (TDF) on renal function... -
- CITED
-
- Close
- SHARE
-
- Close
